EC approves CROMA Pharma, Bausch + Lomb Yellox
Yellox is a non-steroidal anti-inflammatory drug (NSAID) indicated as a treatment for postoperative ocular inflammation following cataract extraction in adults. Under an agreement signed between CROMA Pharma and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.